PapanasNLazaridesMK. Diabetic foot amputations in Greece: where do we go from here?Int J Low Extrem Wounds. 2011;10:4-5.
2.
PapanasNMaltezosEEdmondsM. Salvation of the diabetic foot: still a quest for the Holy Grail?Vasa. 2011;40:267- 269.
3.
BoultonAJ. The diabetic foot: grand overview, epidemiology and pathogenesis. Diabetes Metab Res Rev. 2008;24(suppl 1):S3-S6.
4.
LipskyBAPetersEJBerendtAR; International Working Group on Diabetic Foot. Specific guidelines for the treatment of diabetic foot infections 2011. Diabetes Metab Res Rev. 2012;28(suppl 1):234-235.
5.
Macías HernándezAEAlvarezJACabezadeVacaF. Microbiology of the diabetic foot: is the swab culture useful?Gac Med Mex. 2011;147:117-124.
6.
TiwariSPratyushDDDwivediAGuptaSKRaiMSinghSK. Microbiological and clinical characteristics of diabetic foot infections in northern India. J Infect Dev Ctries. 2012;6:329-332.
7.
DemetriouMPapanasNPanopoulouMPapatheodorouKBounovasAMaltezosE. Tissue and swab culture in diabetic foot infections: neuropathic vs. neuroischaemic ulcers. Int J Low Extrem Wounds. 2013;12:87-93.
8.
ByrenIPetersEJHoeyCBerendtALipskyBA. Pharmacotherapy of diabetic foot osteomyelitis. Expert Opin Pharmacother. 2009;10:3033-3047.
9.
MichailMJudeELiaskosC. The performance of serum inflammatory markers for the diagnosis and follow-up of patients with osteomyelitis. Int J Low Extrem Wounds. 2013;12: 94–99.
10.
DinhTSnyderGVevesA. Current techniques to detect foot infection in the diabetic patient. Int J Low Extrem Wounds. 2010;9:24-30.
11.
DinhMTAbadCLSafdarN. Diagnostic accuracy of the physical examination and imaging tests for osteomyelitis underlying diabetic foot ulcers: meta-analysis. Clin Infect Dis. 2008;47:519-527.
12.
LobmannRSchultzGLehnertH. Proteases and diabetic foot syndrome: mechanisms and therapeutic implications. Diabetes Care. 2006;28:461-471.
13.
AmbroschAHalevyDFwityBBrinTLobmannR. Effect of daptomycin on local interleukin-6 (IL-6), matrix metalloproteinase-9 (MMP-9) and metallopeptidase inhibitor 1 (TIMP-1) in patients with MRSA-infected diabetic foot. Int J Low Extrem Wounds. 2013;12: 100–105.
14.
AmbroschALobmannRPottAPreisslerJ. IL-6 concentrations rather than serological markers are useful in assessing bacterial triggers of ulcer inflammation. Int Wound J. 2008;5:99-106.
15.
DinhTTecilazichFKafanasA. Mechanisms involved in the development and healing of diabetic foot ulceration. Diabetes. 2012;61:2937-2947.
16.
LobmannRZemlinCMotzkauMReschkeKLehnertH. Expression of matrix metalloproteinases and growth factors in diabetic foot wounds treated with protease absorbent dressing. J Diabetes Complications. 2006;20:329-335.
17.
DavisSLRybakMJAmjadMKaatzGWMcKinnonPS. Characteristics of patients with healthcare-associated infection due to SCCmec type IV methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol. 2006;27:1025-1031.
18.
FengS-HChuY-JWangP-HJunXMinDLiX-M. Risk factors and gene type for infections of MRSA in diabetic foot patients in Tian Jin of China. Int J Low Extrem Wounds. 2013;12: 106–112.
19.
LöfflerMWSchusterHBühlerSBeckertS. Wound fluid in diabetic foot ulcerations—more than just an undefined soup?Int J Low Extrem Wounds. 2013;12: 113– 129.
20.
SchmohlMBeckertSJoosTOKönigsrainerASchneiderhan-MarraNLöfflerMW. Superficial wound swabbing: a novel method of sampling and processing wound fluid for subsequent immunoassay analysis in diabetic foot ulcerations. Diabetes Care. 2012;35:2113-2120.
21.
LöfflerMZiekerDWeinreichJ. Wound fluid lactate concentration: a helpful marker for diagnosing soft-tissue infection in diabetic foot ulcers? Preliminary findings. Diabet Med. 2011;28:175-178.
22.
Aragón-SánchezJ. Treatment of diabetic foot osteomyelitis: a surgical critique. Int J Low Extrem Wounds. 2010;9:37-59.
23.
Aragón-SánchezJ. Seminar review: a review of the basis of surgical treatment of diabetic foot infections. Int J Low Extrem Wounds. 2011;10:33-65.
24.
Aragón-SánchezJ. Evidences and controversies about recurrence of diabetic foot osteomyelitis: a personal view and an illustrated guide for understanding. Int J Low Extrem Wounds. 2012;11:88-106.
25.
Aragón-SánchezJLázaro-MartínezJLQuintana-MarreroY. Super-oxidized solution (Dermacyn Wound Care) as adjuvant treatment in the postoperative management of complicated diabetic foot osteomyelitis: preliminary experience in a specialized department. Int J Low Extrem Wounds. 2013; 12:130–137.
26.
GeorgakarakosECharalampidisDKakagiaDGeorgiadisGSLazaridesMKPapanasN. Current Achievements With Topical Negative Pressure to Improve Wound Healing in Dehiscent Ischemic Stumps of Diabetic Patients: A Case Series.Int J Low Extrem Wounds. 2013;12: 138–145.
27.
SchintlerMV. Negative pressure therapy: theory and practice. Diabetes Metab Res Rev. 2012;28(suppl 1):72-77.
28.
Aragón-SánchezJLázaro-MartínezJLMolinés-BarrosoRGarcía ÁlvarezYQuintana-MarreroYHernández-HerreroMJ. Revision surgery for diabetic foot infections: giving another chance to the patient. Int J Low Extrem Wounds. 2013;12:146–151.
29.
Aragón-SánchezJQuintana-MarreroYLázaro-MartínezJL. Necrotizing soft-tissue infections in the feet of patients with diabetes: outcome of surgical treatment and factors associated with limb loss and mortality. Int J Low Extrem Wounds. 2009;8:141-146.
30.
LöndahlM. Hyperbaric oxygen therapy as adjunctive treatment of diabetic foot ulcers. Int J Low Extrem Wounds. 2013; 12:152–157.
31.
TiakaEKPapanasNManolakisACMaltezosE. The role of hyperbaric oxygen in the treatment of diabetic foot ulcers. Angiology. 2012;63:302-314.
32.
LöndahlMKatzmanPNilssonAHammarlundC. Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes. Diabetes Care. 2010;33:998-1003.
33.
LöndahlMKatzmanPHammarlundCNilssonALandin-OlssonM. Relationship between ulcer healing after hyperbaric oxygen therapy and transcutaneous oximetry, toe blood pressure and ankle-brachial index in patients with diabetes and chronic foot ulcers. Diabetologia. 2011;54:65-68.
34.
ViswanathanVRaoNV. Managing diabetic foot infection in India. Int J Low Extrem Wounds. 2013;12:158–166.
35.
PapanasNMaltezosE. Polyherbal formulation as a therapeutic option to improve wound healing in the diabetic foot. Indian J Med Res. 2011;134:146-147.
36.
MoronaJKBuckleyESJonesSReddinEAMerlinTL. Comparison of the clinical effectiveness of different off-loading devices for the treatment of neuropathic foot ulcers in patients with diabetes: a systematic review and meta-analysis. Diabetes Metab Res Rev. 2013;29:183-193.
37.
AntonoglouCPapanasNMaltezosE. Lipid-lowering therapy in the diabetic foot: seeing the whole iceberg and not just the tip [published online September12, 2012]. Curr Vasc Pharmacol.
38.
PapanasNMaltezosE. Growth factors in the treatment of diabetic foot ulcers: new technologies, any promises?Int J Low Extrem Wounds. 2007;6:37-53.
39.
PapanasNMaltezosEEdmondsM. The diabetic foot: a plea for the elementary?Acta Diabetol. 2006;43:152-153.
40.
EdmondsM. Modern treatment of infection and ischaemia to reduce major amputation in the diabetic foot [published online December26, 2012]. Curr Pharm Des.
